Construction projects on Campus Virchow-Klinikum

This page provides updates on construction projects currently underway on Campus Virchow-Klinikum.

You are here:

Current Projects

Berlin Center of Advanced Therapies (BeCAT)

Berlin Center of Advanced Therapies (BeCAT), Visualisierung: IMAGINA | Visual Collaboration
Berlin Center of Advanced Therapies (BeCAT), artist’s impression: IMAGINA | Visual Collaboration

Work is currently underway on Campus Virchow-Klinikum to develop the Berlin Center for Advanced Therapies (BeCAT), which will form part of the new Seestraße research campus. Set to be completed by 2023, the center will focus on the development of new medicines and innovative treatments in regenerative medicine, hematology and oncology.

BeCAT forms part of a bigger campus enlargement concept, which was developed as part of an urban planning competition. All new buildings are arranged around a campus square in such a way as to shield it from all surrounding roads and traffic. The building consists of a basement level and two or three upper levels (split-level design), with laboratories and a dedicated technology level.

Joint campus of Charité and TU

Artist’s impression of the new campus Copyright: HDR, Düsseldorf
Artist’s impression of the new campus Copyright: HDR, Düsseldorf

CharitéUniversitätsmedizin Berlin and Technische Universität Berlin are transforming their current collaborative efforts into a strategic partnership and developing a joint biotechnology and medical technology campus. Situated along Seestraße, the 11,800 m2 (127,000 ft2) site will see physicians work alongside experts from the natural sciences and engineering to address research questions from the fields of oncology, immunology and regenerative medicine. The centerpiece of this new campus will be the new SiM research building (SiM stands for ‘Der Simulierte Mensch’ [‘The Simulated Human’]) which boasts a floor space of 3,150 m2 (33,900 ft2).

Following an open urban design ideas competition, a jury of experts selected the winning designs in January 2019. These had been submitted by architectural firm HDR and landscape architects mk.landschaft. The aim of the competition was to invite design ideas for both the campus and the new SiM research building. In April 2018, the German Council of Science and Humanities recommended that the building be awarded a total of €34 million in funding. This funding is provided via the investment program for large-scale research facilities, which is jointly financed by the federal government and the Berlin state government. The building is expected to be completed by 2023.

Completed Projects

Modern biobank featuring wooden frame construction

Biobank on Campus Virchow-Klinikum, Photo: Wiebke Peitz/Charité
Biobank on Campus Virchow-Klinikum, Photo: Wiebke Peitz/Charité

Berlin 2016 saw the opening of a new biobank which is jointly run by CharitéUniversitätsmedizin Berlin and the Berlin Institute of Health (BIH). An infrastructural addition to Campus Virchow-Klinikum which is unique in Germany, the new biobank has the capacity to accept a total of two million samples and offers researchers access to a wide range of services. The BIH and Charité invested a combined total of €3.9 million into this project. The state-of-the-art building is one of the first laboratory facilities in Germany to feature a timber frame. Weight, erection time, costs and sustainability criteria were deciding factors in this decision.

The biobank will accept samples from Charité patients and samples collected in the course of BIH-based clinical research projects. A proven data protection strategy ensures the optimal safety of both samples and patient data. This is based on a double pseudomymization process, i.e. a pseudonymization algorithm which uses two separate key codes, making re-identification impossible.

Post Anesthesia Care Unit (PACU)

PACU
PACU

Campus Virchow-Klinikum saw the addition of a new Post Anesthesia Care Unit (PACU) with 10 beds. This unit provides postsurgical patients with up to 24 hours of intensive medical care and monitoring. The PACU was created by reorganizing existing space and facilities, along with constructing a central monitoring unit.
 
Facts and numbers
Floor area: 750 m2 (8070 ft2)
Total duration of construction: July 2013 to January 2015 (four construction phases)
Total cost of construction: €2.7 million

New emergency power system on Campus Virchow-Klinikum (CVK)

External site July 2014
Diesel generator unit

The ‘Emergency Diesel Generator’ project formed part of Charité's Master Plan. All of the project’s component measures were completed by December 2014. The state-of-the-art high-voltage substation is housed in its own dedicated building and contains two emergency diesel generators, which can be used to provide additional power. The new emergency power system led to a restructuring of the power supply on Campus Virchow-Klinikum.
 
Facts and numbers
• Total duration of construction: January 2013 to December 2014
• Total cost of construction: €5.6 million

Renovation and refurbishment of the former dental hospital

Ongoing construction work for the BCRT, Berlin Brandenburg Centre for Regenerative Therapies
Ongoing construction work on the BCRT Berlin-Brandenburg Center for Regenerative Therapies

The Federal Government’s second stimulus package (Konjunkturpaket II) provided funding for the renovation and refurbishment of the former dental hospital. The new, two-story research and competence center, which was completed in 2012, comprises seminar rooms and offices. The facilities are used by one of Charité’s Excellence Projects, as well as the Berlin-Brandenburg School for Regenerative Therapies (BSRT) Graduate School and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT). Other users include the Institute of Immunology, the Institute of Human Genetics and the Julius-Wolff Institute.

The building’s centerpiece is a laboratory built and maintained to GMP (Good Manufacturing Practice) standards which meets the highest safety requirements. The laboratory will be used for the development of new drugs, including cancer drugs.